--- title: "Hong Kong Biotech Stocks Decline Amid Market Volatility" type: "News" locale: "en" url: "https://longbridge.com/en/news/285017262.md" description: "Hong Kong's biotechnology sector is facing a downturn, with notable declines in key stocks. Akeso Inc.dropped over 9%, Rongchang Biopharmafell more than 4%, and Junshi Biosciencesdecreased by over 3%. This market volatility has negatively affected investor sentiment in the biotech industry." datetime: "2026-05-04T02:00:29.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285017262.md) - [en](https://longbridge.com/en/news/285017262.md) - [zh-HK](https://longbridge.com/zh-HK/news/285017262.md) --- # Hong Kong Biotech Stocks Decline Amid Market Volatility Hong Kong's biotechnology sector experienced a downturn, with several key stocks showing significant declines. According to Jin10, Akeso Inc. (09926.HK) saw a drop of over 9%, Rongchang Biopharma (09995.HK) fell more than 4%, and Junshi Biosciences (01877.HK) decreased by over 3%. The market volatility has impacted investor sentiment in the biotech industry. ### Related Stocks - [09995.HK](https://longbridge.com/en/quote/09995.HK.md) - [01877.HK](https://longbridge.com/en/quote/01877.HK.md) - [688180.CN](https://longbridge.com/en/quote/688180.CN.md) - [159615.CN](https://longbridge.com/en/quote/159615.CN.md) - [159506.CN](https://longbridge.com/en/quote/159506.CN.md) - [513700.CN](https://longbridge.com/en/quote/513700.CN.md) - [159316.CN](https://longbridge.com/en/quote/159316.CN.md) - [520880.CN](https://longbridge.com/en/quote/520880.CN.md) - [520690.CN](https://longbridge.com/en/quote/520690.CN.md) - [513120.CN](https://longbridge.com/en/quote/513120.CN.md) - [09926.HK](https://longbridge.com/en/quote/09926.HK.md) - [688331.CN](https://longbridge.com/en/quote/688331.CN.md) ## Related News & Research - [RemeGen Deploys Idle Cash Into RMB453 Million HTSC Wealth Products](https://longbridge.com/en/news/286484178.md) - [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md) - [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md) - [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md) - [Wuxi AppTec to Raise Around $1 Billion Through Zero Coupon Convertible Bonds](https://longbridge.com/en/news/286487023.md)